Latest News
Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
27 February 2008
Circassia Raises £11 million ($21.8 million) In Oversubscribed Second Round Funding
29 January 2008
Circassia Completes In-Licensing of Anti-Allergy Intellectual Property Portfolio
29 November 2007
Circassia Initiates Clinical Blood Sample Trial With Organ Anti-Rejection Technology
29 September 2007
Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
12 July 2007
Did you know?
The average bed could be home to up to 1.5 million house dust mites